BSX - Boston Scientific Corporation

NYSE - NYSE Delayed Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents146,000188,000196,000319,000
Short Term Investments----
Net Receivables1,608,0001,548,0001,472,0001,275,000
Inventory1,166,0001,078,000955,0001,016,000
Other Current Assets1,082,0001,008,000616,000804,000
Total Current Assets4,002,0003,822,0003,239,0003,471,000
Long Term Investments423,000352,000347,000-
Property, plant and equipment1,782,0001,697,0001,630,0001,490,000
Goodwill7,911,0006,998,0006,678,0006,473,000
Intangible Assets6,372,0005,837,0005,883,0006,194,000
Accumulated Amortization----
Other Assets509,000336,000319,000505,000
Deferred Long Term Asset Charges87,00088,00080,00040,000
Total Assets20,999,00019,042,00018,096,00018,133,000
Current Liabilities
Accounts Payable349,000530,000447,000209,000
Short/Current Long Term Debt1,297,0001,801,00064,0003,000
Other Current Liabilities1,218,0002,079,0001,889,0001,140,000
Total Current Liabilities5,260,0005,654,0003,587,0002,430,000
Long Term Debt4,797,0003,814,0005,419,0005,674,000
Other Liabilities2,210,0002,561,0002,356,0003,709,000
Deferred Long Term Liability Charges----
Minority Interest----
Negative Goodwill----
Total Liabilities12,273,00012,030,00011,363,00011,813,000
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock16,00016,00016,00016,000
Retained Earnings-6,953,000-8,390,000-8,581,000-8,927,000
Treasury Stock-1,683,000-1,775,000-1,716,000-1,629,000
Capital Surplus17,346,00017,161,00017,014,00016,860,000
Other Stockholder Equity34,000-58,0001,00088,000
Total stockholders' equity8,726,0007,012,0006,733,0006,320,000
Net Tangible Assets-5,557,000-5,823,000-5,828,000-6,347,000